C

Clearside Biomedical
D

CLSD

0.82900
USD
0.01
(1.44%)
مغلق
حجم التداول
30
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
64,420,376
أصول ذات صلة
C
CRSP
0.455
(0.88%)
52.120 USD
C
CRVS
-0.03500
(-0.88%)
3.95500 USD
E
EDIT
0.02000
(0.78%)
2.57000 USD
N
NTLA
-0.020
(-0.19%)
10.710 USD
R
RGNX
0.11000
(1.28%)
8.72000 USD
S
SGMO
0.00200
(0.38%)
0.53200 USD
V
VCEL
0.130
(0.31%)
41.600 USD
المزيد
الأخبار المقالات

العنوان: Clearside Biomedical

القطاع: Healthcare
الصناعة: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.